Corrigendum to The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma. Toxicology and Applied Pharmacology 332 (2017) 1–7 (S0041008X17303095) (10.1016/j.taap.2017.07.012))

Yu Mei Hsueh, Ying Chin Lin, Wei Jen Chen, Chao Yuan Huang, Horng Sheng Shiue, Yeong Shiau Pu, Chi Hung Chen, Chien Tien Su

Research output: Contribution to journalErratum

Abstract

Because of our mistakes, we hope we can have the opportunity to make corrections, do not affect Dr. Lin's promotion. Affiliation “e” of Dr. Ying-Chin Lin, which was incorrectly given as. “e Division of Family Medicine, School of Medicine, Taipei Medical University, Taipei, Taiwan”. The correct affiliation of Dr. Lin is listed below: “e Department of Family Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.”

Original languageEnglish
Number of pages1
JournalToxicology and Applied Pharmacology
Volume356
DOIs
Publication statusPublished - Oct 1 2018

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology

Fingerprint Dive into the research topics of 'Corrigendum to The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma. Toxicology and Applied Pharmacology 332 (2017) 1–7 (S0041008X17303095) (10.1016/j.taap.2017.07.012))'. Together they form a unique fingerprint.

  • Cite this